Poster

Characterization of human iPSC-derived motor neuron disease model for ALS drug discovery

Development of photoreceptor outer segments in human iPSC-derived retinal organoids produced at large scale

Generation of a physiologically relevant in vitro model of autosomal dominant Retinitis Pigmentosa caused by RHO-P23H mutation using 3D retinal organoids

Comparison of multiple batches of human iPSC-derived retinal organoids produced at large scale

Development of a human iPSC-derived retinal microphysiological co-culture system for dry age-related macular degeneration

New Approach Methodologies (NAMs): assessing cardiotoxicity and neurotoxicity in vitro using human iPSC-derived cells

Modeling ALS with iPSC-derived motor neurons, microglia and astrocytes

Establishing a robust platform for investigating the pro-and anti-inflammatory response of iPSC-derived microglia in drug discovery

Evaluation of a new media designed to drive improved maturity of iPSC-derived cardiomyocytes for cardiac disease, cardiotoxicity and drug screening

Creation of RUES2 Cell Lines Carrying Targeted Modifications at the HTT Gene